Search research articles
Contact Us
Filters
Showing results (81-90 of 169) with videos related to
Page
of 17
Sort By:
Digestive Diseases and Sciences
|
December 24, 2014
Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection
Maria Buti, Naoky Tsai, Joerg Petersen, et al.
JCI Insight
|
January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis
Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Journal of Hepatology
|
June 11, 2018
Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients
Kosh Agarwal, Lluís Castells, Beat Müllhaupt, et al.
Journal of Lipid Research
|
July 14, 2022
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients
Eric J Lawitz, Kelvin W Li, Edna Nyangau, et al.
Journal of Hepatology
|
December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Kosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.
Annals of Internal Medicine
|
November 4, 2014
Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study
Anu Osinusi, Anita Kohli, Miriam M Marti, et al.
Gastroenterology
|
August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection
Graham R Foster, Stephen Pianko, Ashley Brown, et al.
The New England Journal of Medicine
|
July 10, 2009
Raxibacumab for the treatment of inhalational anthrax
Thi-Sau Migone, G Mani Subramanian, John Zhong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2016
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Jason Grebely, Gregory J Dore, Stefan Zeuzem, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 169) with videos related to
Sort By:
Page
of 17
Digestive Diseases and Sciences
|
December 24, 2014
Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection
Maria Buti, Naoky Tsai, Joerg Petersen, et al.
JCI Insight
|
January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis
Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Journal of Hepatology
|
June 11, 2018
Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients
Kosh Agarwal, Lluís Castells, Beat Müllhaupt, et al.
Journal of Lipid Research
|
July 14, 2022
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients
Eric J Lawitz, Kelvin W Li, Edna Nyangau, et al.
Journal of Hepatology
|
December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Kosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.
Annals of Internal Medicine
|
November 4, 2014
Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study
Anu Osinusi, Anita Kohli, Miriam M Marti, et al.
Gastroenterology
|
August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection
Graham R Foster, Stephen Pianko, Ashley Brown, et al.
The New England Journal of Medicine
|
July 10, 2009
Raxibacumab for the treatment of inhalational anthrax
Thi-Sau Migone, G Mani Subramanian, John Zhong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2016
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Jason Grebely, Gregory J Dore, Stefan Zeuzem, et al.
Page
of 17